of acute asthma during pregnancy19 Chapter 27Table 27.1 Rates of adverse pregnancy outcome in observational studies descri...Table 27.2 Drugs used to treat hypertension in pregnancy
20 Chapter 29Table 29.1 Clinical manifestations of syphilis in the adult
21 Chapter 32Table 32.1 Presentation of malaria in pregnancy by underlying endemicityTable 32.2 Recommendations for travel to a malarious area during pregnancy
22 Chapter 33Table 33.1 Baseline laboratory studies for pregnant women living with HIV
23 Chapter 34Table 34.1 Results of maternal serological testing for parvovirus B19 infecti...
24 Chapter 35Table 35.1 Rate of early‐onset neonatal GBS sepsis in the presence of materna...Table 35.2 Recommended regimens for intrapartum antibiotic prophylaxisa
25 Chapter 37Table 37.1 Summary of evidence for management of cervical insufficiency by di...Table 37.2 Use of cerclage in singleton gestations
26 Chapter 38Table 38.1 Pregnancy‐Unique Quantification of Emesis (PUQE) indexTable 38.2 Differential diagnosis of nausea and vomitingTable 38.3 Initial laboratory evaluationTable 38.4 Pharmacological agents for use in nausea and vomiting in pregnancy
27 Chapter 40Table 40.1 Association of oligohydramnios and adverse perinatal outcomeTable 40.2 Comparison of use of amniotic fluid index or mean vertical pocket ...Table 40.3 Etiologies of polyhydramniosTable 40.4 Outcomes of polyhydramnios based on severity
28 Chapter 41Table 41.1 Selected FGR etiologies and associations
29 Chapter 42Table 42.1 Non‐RhD antibodies and associated hemolytic disease of the fetus o...Table 42.2 Other indications for Rhesus immune globulin administration
30 Chapter 43Table 43.1 Survival and major morbidities by gestational age at birth in 2008
31 Chapter 44Table 44.1 Risk factors for preterm birth
32 Chapter 46Table 46.1 Timing of indicated deliveries in the late‐preterm and early‐term ...
33 Chapter 47Table 47.1 Abnormal amniotic fluid results confirmatory of intraamniotic infe...
34 Chapter 48Table 48.1 Blood product replacementsTable 48.2 Causes of third‐trimester bleeding
35 Chapter 49Table 49.1 Proposed diagnostic criteria for the case definition of AFETable 49.2 Differential diagnosis of AFETable 49.3 Agents used in cardiovascular resuscitation and right‐sided heart ...
36 Chapter 50Table 50.1 Drugs used to treat hypertension in pregnancyTable 50.2 Protocols for treatment of severe hypertension (systolic blood pre...
37 Chapter 51Table 51.1 Elective induction of labor checklist among low‐risk women with ve...Table 51.2 Bishop pelvic scoring systemTable 51.3 Examples of low‐ and high‐dose oxytocin infusion protocols for lab...Table 51.4 Clinical pearls for the diagnosis of failed labor inductionTable 51.5 Elective induction of labor: a framework for shared decision makin...
38 Chapter 52Table 52.1 Standardized fetal heart rate (FHR) definitionsTable 52.2 Fetal heart rate (FHR) categoriesTable 52.3 Potential causes of prolonged decelerationTable 52.4 Intrapartum FHR monitoring “ABCD” checklist
39 Chapter 56Table 56.1 Risk (%) for shoulder dystocia based on fetal weight, diabetic sta...
40 Chapter 57Table 57.1 Frequency of presentationTable 57.2 Maternal complications inmultifetal pregnanciesTable 57.3 Fetal complications in multifetal pregnanciesTable 57.4 Staging of twin‐to‐twin transfusion syndrome
41 Chapter 58Table 58.1 Risk factors for postpartum hemorrhageTable 58.2 Medical treatment for uterine atony
42 Appendix ATable A.1 Relationship between nuchal translucency thickness and pregnancy outco...Table A.2 Estimated rates of karyotypic abnormalities related to maternal age at...Table A.3 Performance of cell‐free DNA screening for common aneuploidiesTable A.4 Significance of chromosomal microarray in fetuses with normal karyotyp...Table A.5 Frequency of chromosome aberrations in newborns (modified from a summa...Table A.6 Common conditions that can be screened for using cell‐free DNATable A.7 Common disorders that can be diagnosed prenatally by invasive genetic ...Table A.8 Relative timing and developmental pathology of certain malformations...Table A.9 Performance of first‐trimester ultrasound in detection of fetal anomal...Table A.10 Expected detection rates of fetal malformations in the first trimeste...Table A.11 Expected detection rates of fetal malformations in the second trimest...Table A.12 Prevalence of major cardiac defects by nuchal translucency thickness ...Table A.13 Screening for congenital heart disease: performance of current strate...Table A.14 Increased risk for neural tube defect (NTD)Table A.15 Serial sonographic surveillance for twin pregnanciesTable A.16 Staging criteria for twin–twin transfusion syndromeTable A.17 Drugs associated with congenital malformations in humansTable A.18 Hemolytic disease resulting from irregular antibodiesTable A.19 Fetal blood sampling
List of Illustrations
1 Chapter 5Figure 5.1 Nuchal translucency (NT) ultrasound measurement at 13 weeks’ gest...Figure 5.2 Increased nuchal translucency measurement at 13 weeks’ gestation ...Figure 5.3 Nasal bone image of a euploid fetus at 13 weeks. Various features...
2 Chapter 7Figure 7.1 Schematic representing zero angle of insonation between the Doppl...Figure 7.2 Flow velocity waveform of the umbilical artery and definitions fo...
3 Chapter 9Figure 9.1 A typical procedure tray set‐up for cordocentesis, with 22 gauge ...Figure 9.2 A typical OR procedure table set‐up for fetal blood transfusion.
4 Chapter 11Figure 11.1 Causes of maternal anemia, classified by mean corpuscular volume...Figure 11.2 Algorithm for evaluation of normocytic anemia.Figure 11.3 Algorithm for evaluation of microcytic anemia.
5 Chapter 17Figure 17.1 Cardiovascular adaptation to pregnancy. HR, heart rate; MAP, mea...
6 Chapter 18Figure 18.1 Diagnostic approach to the patient presenting with cardiopulmona...Figure 18.2 Differential diagnosis for heart failure with reduced ejection f...Figure 18.3 Contemporary understanding of the pathophysiology of peripartum ...Figure 18.4 Framework and clinical pearls for stabilization and ongoing mana...
7 Chapter 19Figure 19.1 Exponential increase in venous thromboembolism risk during pregn...Figure 19.2 Coagulation pathway.Figure 19.3 Coagulation factor changes in pregnancy.Figure 19.4 Virchow’s triad associated with pregnancy.Figure 19.5 Pregnancy‐adapted YEARS algorithm for diagnosis of suspected pul...Figure 19.6 Algorithm for diagnosis and management of suspected pulmonary em...
8 Chapter 22Figure 22.1 Initation of insulin treatment in a GDM 75 kg patient at 28 week...
9 Chapter 24Figure 24.1 CDC‐recommended treatment
